Federal resistance threats · methods
CDC threat categories summarize national public-health concern using a dated evidence base. “Urgent,” “serious,” “concerning” and the watch list are policy categories, not predictions about an individual infection.
What the current federal page describes
CDC’s current threats page is anchored to the 2019 Antibiotic Resistance Threats Report, which covers 18 antimicrobial-resistant bacteria and fungi. The page organizes germs into urgent, serious and concerning categories and a watch list.
The same page points to a separate 2021–2022 update for hospital-onset infections and states that a future electronic release is planned. These products have different data years and scopes. An editor should not call the 2019 burden estimates “2026 data” merely because the webpage was retrieved in 2026.
When a newer release appears, it may use different databases, modeled methods or organism definitions. A changed estimate should be attributed to the new analysis; it is not automatically a like-for-like trend from the older report.
Five dates that prevent stale reporting
- Report publication date
- Years represented by the underlying data
- Date of any special update or supplement
- Webpage revision date
- Newsroom retrieval and publication dates
Threat categories reflect population burden, trends, preventability, treatment options and other public-health considerations. They do not tell a patient how severe a particular infection will be.
A methods-first reading sequence
- Confirm which organisms and drug-resistance definitions are included.
- Identify surveillance systems, healthcare or community settings and modeled estimates.
- Keep reported counts separate from estimated national burden.
- Report uncertainty, exclusions and changes from earlier methods.
- Use the exact current release rather than carrying forward an old headline.
What the report cannot support
A national threats report cannot diagnose infection, rank local clinicians or recommend a medicine. Public readers should use it to understand policy priorities; personal testing and treatment questions require qualified clinical care.